Browsing: Commits

Veeva Systems (NYSE: VEEV) announced that Regeneron Pharmaceuticals has committed to deploy Veeva Vault CRM globally across its commercial organization. Regeneron plans to use the AI-powered platform to generate Commercial Evidence from field engagement, identify barriers to treatment adoption, and support faster, data-informed commercial decisions.

Veeva Systems (NYSE: VEEV) announced on August 11, 2026 that Eli Lilly and Company has committed to deploy Veeva Vault CRM globally. Vault CRM is part of the Vault CRM Suite, which Veeva describes as the technology foundation for agentic commercial, a new AI-enabled commercial model to help bring the right medicines to more patients.